Axplora- The partner of choice for complex APIs.
01 1Farmabios S.p.A.
02 1Cipla Ltd.
01 1CYPROTERONE ACETATE
02 1Cyproterone Acetate
01 1Germany
02 1India
Axplora- The partner of choice for complex APIs.
NDC Package Code : 46439-8720
Start Marketing Date : 1998-05-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7635
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
A Cyproterone Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyproterone Acetate, including repackagers and relabelers. The FDA regulates Cyproterone Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyproterone Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cyproterone Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cyproterone Acetate supplier is an individual or a company that provides Cyproterone Acetate active pharmaceutical ingredient (API) or Cyproterone Acetate finished formulations upon request. The Cyproterone Acetate suppliers may include Cyproterone Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Cyproterone Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cyproterone Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cyproterone Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cyproterone Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cyproterone Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cyproterone Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cyproterone Acetate suppliers with NDC on PharmaCompass.
LOOKING FOR A SUPPLIER?
